Dr. George M. Milne

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dr. George M. Milne

Earlier roles on record: Board Member at Aurinia Pharmaceuticals Inc. (AUPH) until June 29, 2023. Aurinia Pharmaceuticals Inc. reported in an 8-K filed July 3, 2023 that Dr. George M. Milne resigned as director, effective June 29, 2023.

“the Board, following the deliberation process outlined in the Company's Majority Voting Policy, determined to accept the resignations of Dr. Milne and Mr. Hagan effective June 29, 2023.”

Aurinia Pharmaceuticals Inc. Form 8-K, filed July 3, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Dr. George M. Milne's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Aurinia Pharmaceuticals Inc. (AUPH)
Proxy statement

Start not stated–2023-04-18

Last confirmed by a filing; no departure on record
Aurinia Pharmaceuticals Inc. (AUPH)
Board Member

Proxy statement

Start not stated–2023-06-29

Company network

Recorded roles and call appearances connecting this person to public companies.

Aurinia Pharmaceuticals Inc.

AUPH

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: director Aurinia Pharmaceuticals Inc. (AUPH)
2023-06-29